Evidence map›Paper›PMID 41684906›Full record

ArticleOpen respiratory archives

[Prevalence of electronic cigarette use and refill compositions among young people and adults in Cantabria].

Pablo David Fernández-Carrillo, María Fernanda García-Román, Rubén Arlegui-Tricio, Rocío Saiz-Villena, Miguel Santibáñez, David Peña-Otero

Abstract readEnglish Abstract
In one paragraph

Article in Open respiratory archives. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pablo David Fernández-CarrilloCentro de Salud Astillero, Servicio Cántabro de Salud, Astillero, España.
María Fernanda García-RománCentro de Salud Bezana, Servicio Cántabro de Salud, Santa Cruz de Bezana, España.
Rubén Arlegui-TricioCentro de Salud Bezana, Servicio Cántabro de Salud, Santa Cruz de Bezana, España.
Rocío Saiz-VillenaCentro de Salud Dávila, Servicio Cántabro de Salud, Santander, España.
Miguel SantibáñezGlobal Health Research Group, Universidad de Cantabria, Santander, España.
David Peña-OteroGrupo de Enfermería, Instituto de Investigación Marqués de Valdecilla (IDIVAL), Santander, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Electronic cigarettes (ECs) or vapes, have attracted interest among both young people and adults for recreational and social reasons. The aim of this study is to determine the prevalence of EC use by gender and age in Cantabria (northern Spain), as well as the composition of the refills. Material and methods: Cross-sectional study based on an anonymous, self-administered online questionnaire conducted from February to May 2025 (3 months). A total of 981 surveys were collected from individuals aged 15 to 64 years (inclusive). Results: The overall prevalence of recent use (in the last 30 days) was 4.2%, while lifetime use of EC was 16.2%. By age group, usage was highest among those under 35 years old (27.1% in the 15-24 age group and 24.4% in the 25-34 age group), and below 11% in older age groups. Regarding refill composition, nicotine-containing products were the most commonly used (44.7%), followed by nicotine-free and Conclusions: Methodological limitations aside regarding the representativeness of our sample in relation to the entire community, these findings are consistent with national data from the latest Survey on Alcohol and Drugs in Spain (EDADES 2024), highlighting the need to design targeted intervention strategies for the young population.

Indexed as

Electronic cigarettePrevalenceVaping

Identifiers

PMID41684906
PMCPMC12892055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.